From: Biomarkers for antitumor activity of bevacizumab in gastric cancer models
Cell line | Sensitivity to bevacizumab | VEGF | PlGF | IL-8 | bFGF |
---|---|---|---|---|---|
COL-16-JCK | + | 4430 ± 991 | < 15.6 | 360 ± 171 | 268 ± 75.3 |
SC-08-JCK | + | 2330 ± 402 | < 15.6 | < 31.3 | 145 ± 25.9 |
GXF97 | + | 1950 ± 753 | < 15.6 | 362 ± 134 | 107 ± 63.6 |
MKN-45 | + | 1560 ± 310 | < 15.6 | 65.9 ± 9.38 | 183 ± 43.0 |
CXF280 | + | 1480 ± 290 | < 15.6 | < 31.3 | 77.6 ± 16.5 |
SC-09-JCK | + | 1020 ± 163 | < 15.6 | 165 ± 60.3 | 151 ± 13.3 |
4-1ST | + | 706 ± 106 | < 15.6 | < 31.3 | 87.7 ± 5.47 |
MKN-28 | + | 577 ± 285 | 16.4 ± 8.22 | < 31.3 | 200 ± 27.8 |
SC-10-JCK | - | 760 ± 80.2 | < 15.6 | 198 ± 96.5 | 231 ± 105 |
NCI-N87 | - | 171 ± 52.5 | < 15.6 | 34.4 ± 10.8 | 1090 ± 328 |
SCH | - | < 31.3 | 1210 ± 205 | < 31.3 | 38.4 ± 18.6 |